| Day 2 |
07.30-08.30 |
8.30-10.00 |
10.30-12.30 |
12.45-13.45 |
14.00-15.30 |
16.00-17.30 |
Hall 1 |
47- SS 5
ARDS |
54- Symposium 5
Malpractice in Turkish Criminal Law |
62- WG |
62- Clinical Year in Review |
78- Clinical Grand Round 2
(Diagnostic Procedures)
|
86- MS 9
Pathogenesis in COPD |
Hall 2 |
48- SS 6
Follow up criteria other than FEV1 in COPD
|
55- Symposium 6
From theory to practice: Asthma and COPD |
63- WG |
63- Clinical Year in Review |
79- Symposium 8
Sepsis: Molecular characteristics, relation with acute lung damage, new treatment
strategies |
87- Pro-Con Discussion
GER and respiratory diseases |
Hall 3 |
49- SS 7
Obstructive Sleep Apnea: Is it a component of metabolic syndrome? |
56- Round Table 5
Problems related with pneumoconioses |
64- WG |
64- Clinical Year in Review |
80- HT
- The New international classification of sleep disorder (ICSD-2)
- Obesity and Asthma
- Obstructive sleep apnea in childhood and its cardiovascular effects |
88- Round Table 9
How to get hydatid cyst under control |
Hall 4 |
50- SS 8
Surgical treatment of malign pleural diseases |
57- Round Table 6
Tracheal resections |
65- WG |
65- Clinical Year in Review |
81- MS 8
Denim sandblasting as a new occupational disease |
89- Symposium 10
Pulmonary function tests in clinical practice |
Hall 5 |
51- SS 9
Granuloma formation in the lungs |
58- MS 7
New Developments of Lung Cancer Diagnosis and treatment |
66- WG |
66- Clinical Year in Review |
82- Symposium 9
Neoadjuvant Therapy |
90- MS 10
Anti-inflammatory treatment in Asthma |
Hall 6 |
52- SS 10
Approach to tuberculosis with atypical radiology |
59- Symposium 7
Education of tuberculosis in medical school |
67- WG |
67- Clinical Year in Review |
|
91- PDS11
Diagnosis in COPD |
Hall 7 |
53- SS 11
Smoking addiction and new agents in treatment |
60- Round Table 7
Patients who have difficulties with smoking cessation |
68- WG |
68- Clinical Year in Review |
|
92- PDS12
Dispensary Results |
Hall 8 |
|
61- Round Table 8
Weaning |
69- WG |
69- Clinical Year in Review |
|
93- PDS 13
Prognosis and Treatment of Lung and Pleural Malignancies |
Hall 9 |
|
|
70- WG |
70- Clinical Year in Review |
|
94- PDS 14
Lung Pathology |
Hall 10 |
|
|
71- WG |
71- Clinical Year in Review |
|
95- PDS 15
Tuberculosis |
Hall 11 |
|
|
72- WG |
72- Clinical Year in Review |
83- CCC
Respiratory infections |
|
Hall 12 |
|
|
73- WG |
73- Clinical Year in Review |
84- CCC Tuberculosis |
|
Hall 13 |
|
|
74- WG |
74- Clinical Year in Review |
85- CCC COPD |
|
Hall 14 |
|
|
75- WG |
75- Clinical Year in Review |
|
|
Hall 15 |
|
|
76- WG |
76- Clinical Year in Review |
|
|
Poster Hall |
|
|
77- WG |
77-Clinical Year in Review |
|
96- Poster Presentation (P102-148)
97- Poster Presentation (P149-200)
|
